Hemodynamic effects of dexmedetomidine--fentanyl vs. nalbuphine--propofol in plastic surgery

dc.contributorDe la Mora-Gonz�lez, J.F., Department of Anesthesiology, Institute of Reconstructive Surgery of Jalisco, Health Secretary, Guadalajara, Mexico; Robles-Cervantes, J.A., Internal Medicine Service, Institute of Reconstructive Surgery Dr. Jose Guerrero Santos, Guadalajara, Mexico, Medical Research Unit in Clinical Epidemiology, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Mexico; Mora-Mart�nez, J.M., Department of Anesthesiology, Hospital General Zone 14, Mexican Institute of Social Security, Guadalajara, Mexico; Barba-Alvarez, F., Department of Anesthesiology, Institute of Reconstructive Surgery of Jalisco, Health Secretary, Guadalajara, Mexico; De la Cruz Llontop-Pisfil, E., Department of Anesthesiology, Institute of Reconstructive Surgery of Jalisco, Health Secretary, Guadalajara, Mexico; Gonz�lez-Ortiz, M., Medical Research Unit in Clinical Epidemiology, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Mexico, Cardiovascular Research Unit Physiology Department, Health Sciences University Center, University of Guadalajara, Mexico; Mart�nez-Abundis, E., Medical Research Unit in Clinical Epidemiology, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Mexico, Cardiovascular Research Unit Physiology Department, Health Sciences University Center, University of Guadalajara, Mexico; Llamas-Moreno, J.F., Medical Research Unit in Clinical Epidemiology, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Mexico; Berm�dez, M.C.E., Medical Research Unit in Clinical Epidemiology, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Mexico
dc.creatorDe la Mora-Gonzalez, J.F.
dc.creatorRobles-Cervantes, J.A.
dc.creatorMora-Martinez, J.M.
dc.creatorBarba-Alvarez, F.
dc.creatorDe la Cruz Llontop-Pisfil, E.
dc.creatorGonzalez-Ortiz, M.
dc.creatorMartinez-Abundis, E.
dc.creatorLlamas-Moreno, J.F.
dc.creatorBermudez, M.C.E.
dc.date.accessioned2015-09-15T18:05:25Z
dc.date.accessioned2022-11-02T16:29:20Z
dc.date.available2015-09-15T18:05:25Z
dc.date.available2022-11-02T16:29:20Z
dc.date.created2015-09-15T18:05:25Z
dc.date.issued2012
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84866049495&partnerID=40&md5=395d445830f8a69485c5d55c13f61184
dc.identifierhttp://hdl.handle.net/20.500.12104/41867
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5022381
dc.description.abstractDexmedetomidine has demonstrated to be useful in several clinical fields due to its respiratory safety and cardiovascular stability. We undertook this study to determine its usefulness in plastic surgery. Sixty patients were divided into two parallel groups. A group received dexmedetomidine- -fentanyl and the comparison group received nalbuphine--propofol, both with same dose of midazolam. Blood pressure, heart rate and oxygen saturation were determined during the preoperative, intraoperative and recuperation periods. Results. In both groups, hemodynamic constants decreased intraoperatively. Dexmedetomidine--fentanyl decreased more than in the nalbuphine--propofol (systolic blood pressure, p = 0.006; diastolic blood pressure, p = 0.01 and heart rate, p = 0.007). Comparatively, oxygen saturation was greater in the dexmedetomidine-- fentanyl group vs. nalbuphine--propofol (p = 0.0001). Recovery time for the nalbuphine--propofol group was shorter than in the dexmedetomidine--fentanyl group (p = 0.0001). conclusions. Dexmedetomidine shows the same cardiovascular stability but with absence of respiratory depression.
dc.relationScopus
dc.relationMiddle East Journal of Anesthesiology
dc.relation21
dc.relation4
dc.relation553
dc.relation558
dc.titleHemodynamic effects of dexmedetomidine--fentanyl vs. nalbuphine--propofol in plastic surgery
dc.typeArticle


Este ítem pertenece a la siguiente institución